Myricetin-loaded SBA-15 silica nanoparticles for enhanced management of pyrexia, pain, and inflammation through modulation of MAPK/NF-κB and COX-2/PGE-2 pathways: Evidence from the biochemical, histological, and metabolomic analysis

Zeinab A. El‐Gendy, Naglaa M. Ammar, Abdulsalam M. Kassem, Mohamed S. Attia, Sherif M. Afifi, Ahmed H. Ibrahim, Sherif E. Emam, Reda M. S. Korany, Abd El‐Nasser G. El‐Gendy, Abdelsamed I. Elshamy